How to use the speech recognition tool?

NCT03561922

Impact on Daily Life of Patients Using the Subretinal Implant RETINA IMPLANT Alpha AMS

Impact on Daily Life of Patients Using the Subretinal Implant RETINA IMPLANT
Alpha AMS

Type: Interventional



Status of the trial: Completed

Orphan Drug Recognition: NA

Inclusion

  • Opening Date: 2018-09-04
  • Closing Date: 2019-04-05

Criteria

More information

Children: No

Adults: Yes

Funder Type: industry

HCP: Principal investigators

HCP: Other investigators


Within ERN-EYE members

Principal investigators




Other investigators

Workgroups

  • Retinal Rare Eye Diseases (WG1)

Subscribe to our mailing list

* indicates required

This ERN is supported by: